Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options

被引:10
|
作者
Sowell, Josiah [1 ]
Pena, Sandra M. [2 ]
Elewski, Boni E. [2 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Dermatol, 1720 Univ Blvd,Suite 500, Birmingham, AL 35294 USA
关键词
PIMECROLIMUS CREAM 1-PERCENT; DOUBLE-BLIND; SKIN; EFFICACY; DIAGNOSIS; PREVALENCE; MODERATE; TRIAL; ISOTRETINOIN; PERSPECTIVES;
D O I
10.1007/s40266-022-00930-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Seborrheic dermatitis is a common and chronic skin disease, which is particularly prevalent in older adults. While a specific cause of seborrheic dermatitis remains largely unelucidated, the currently understood pathogenesis of seborrheic dermatitis revolves around the presence of Malassezia yeast colonies and an inflammatory response in the affected individual. Keratinocyte proliferation resulting from inflammasome response in the host skin leads to the clinically relevant symptoms of seborrheic dermatitis. The increasing number of older adults as a percentage of the population in the USA will lead to an even higher prevalence of the disease in the ensuing decades. Fortunately, there are multiple treatment options based on individual patient situations and preferences. Topical treatment is the gold standard, but oral therapy may be required in certain cases. In order to maximize effectiveness and minimize adverse pharmacologic effects, effective treatment for older adults must take into account changes in lifestyle and metabolism that occur with aging.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 50 条
  • [1] Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options
    Josiah Sowell
    Sandra M. Pena
    Boni E. Elewski
    [J]. Drugs & Aging, 2022, 39 : 315 - 321
  • [2] Atopic Dermatitis in Older Adults: A Review of Treatment Options
    Ryoji Tanei
    [J]. Drugs & Aging, 2020, 37 : 149 - 160
  • [3] Atopic Dermatitis in Older Adults: A Review of Treatment Options
    Tanei, Ryoji
    [J]. DRUGS & AGING, 2020, 37 (03) : 149 - 160
  • [4] Pathogenesis of seborrheic dermatitis
    Scrivener, Y
    Cribier, B
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2004, 131 (01): : 119 - 122
  • [5] Oral terbinafine for the treatment of seborrheic dermatitis in adults
    Cassano, N
    Amoruso, A
    Loconsole, F
    Vena, GA
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (11) : 821 - 822
  • [6] ON THE ETIOLOGY AND PATHOGENESIS OF INFANTILE SEBORRHEIC DERMATITIS
    SEEBACHER, C
    [J]. MYKOSEN, 1981, 24 (04): : 209 - 215
  • [7] THE TREATMENT OF SEBORRHEIC DERMATITIS
    CIRINCIONE, JL
    [J]. NEW YORK STATE JOURNAL OF MEDICINE, 1952, 52 (17) : 2109 - 2112
  • [8] Treatment for seborrheic dermatitis
    Kupfer-Bessaguet, I
    Misery, L
    Plantin, P
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2004, 131 (11): : 998 - 998
  • [9] Treatment of seborrheic dermatitis
    Johnson, BA
    Nunley, JR
    [J]. AMERICAN FAMILY PHYSICIAN, 2000, 61 (09) : 2703 - 2710
  • [10] Treatment of seborrheic dermatitis
    Quéreux, G
    Dréno, B
    Chosidow, O
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2004, 131 (01): : 130 - 134